This website uses cookies. They allow us to optimize your browsing experience and also help us to understand how you use our site. By continuing to use this website, you accept our use of cookies. Cookie information page
Close

AkzoNobel procures BluCure™ Cobalt-free patent portfolio from DSM

1 March 2017

BluCure logo
 

AkzoNobel announced that it has acquired the entire BluCure™ Cobalt-free patent and trademark portfolio from DSM Resins and Functional Materials. With full ownership of the patent portfolio, the licensing of the combined BluCure™ technologies by AkzoNobel has become easier, enabling a faster adoption in the unsaturated polyester composite industry.

BluCure™ is an umbrella brand of resin curing technologies and products launched jointly by AkzoNobel and DSM in 2012 as a sustainable alternative for Cobalt-based systems which are under pressure for potential reclassification.

“This completion of our patent portfolio is another example of AkzoNobel’s commitment to expanding our product portfolio to provide essential ingredients in a sustainable way to help our customers make people’s lives more livable and inspiring,” said Markus Majoor, AkzoNobel Global Market Segment Leader for Thermoset Chemicals.

“We are pleased to acquire the remaining BluCure™ Cobalt-free patent portfolio positions from DSM,” says Markus Majoor. “This will enable us to license the combined technology in an unconstrained and transparent way to the entire composite Industry.

AkzoNobel is leading the way with a range of breakthrough, Cobalt-free accelerators for the curing of unsaturated polyester and vinyl ester resins that can be used as alternatives for conventional Cobalt-based accelerators.

“We expect these new accelerator technologies to play a key role in the curing of future generation styrene-free resins,” added Majoor.